BACKGROUND: Peanut allergy is typically severe, lifelong, and prevalent. OBJECTIVE: To identify factors associated with peanut sensitization. METHODS: We evaluated 503 infants 3 to 15 months of age (mean, 9.4 months) with likely milk or egg allergy but no previous diagnosis of peanut allergy. A total of 308 had experienced an immediate allergic reaction to cow's milk and/or egg, and 204 had moderate to severe atopic dermatitis and a positive allergy test to milk and/or egg. A peanut IgE level ≥5 kU(A)/L was considered likely indicative of peanut allergy. RESULTS: A total of 140 (27.8%) infants had peanut IgE levels ≥5 kU(A)/L. Multivariate analysis including clinical, laboratory, and demographic variables showed frequent peanut consumption during pregnancy (odds ratio, 2.9; 95% CI, 1.7-4.9; P < .001), IgE levels to milk (P = .001) and egg (P < .001), male sex (P = .02), and nonwhite race (P = .02) to be the primary factors associated with peanut IgE ≥5 kUA/L. Frequency of peanut consumption during pregnancy and breast-feeding showed a dose-response association with peanut IgE ≥5 kU(A)/L, but only consumption during pregnancy was a significant predictor. Among 71 infants never breast-fed, frequent consumption of peanut during pregnancy was strongly associated with peanut IgE ≥5 kU(A)/L (odds ratio, 4.99, 95% CI, 1.69-14.74; P < .004). CONCLUSION: In this cohort of infants with likely milk or egg allergy, maternal ingestion of peanut during pregnancy was strongly associated with a high level of peanut sensitization.
BACKGROUND:Peanut allergy is typically severe, lifelong, and prevalent. OBJECTIVE: To identify factors associated with peanut sensitization. METHODS: We evaluated 503 infants 3 to 15 months of age (mean, 9.4 months) with likely milk or egg allergy but no previous diagnosis of peanut allergy. A total of 308 had experienced an immediate allergic reaction to cow's milk and/or egg, and 204 had moderate to severe atopic dermatitis and a positive allergy test to milk and/or egg. A peanutIgE level ≥5 kU(A)/L was considered likely indicative of peanut allergy. RESULTS: A total of 140 (27.8%) infants had peanutIgE levels ≥5 kU(A)/L. Multivariate analysis including clinical, laboratory, and demographic variables showed frequent peanut consumption during pregnancy (odds ratio, 2.9; 95% CI, 1.7-4.9; P < .001), IgE levels to milk (P = .001) and egg (P < .001), male sex (P = .02), and nonwhite race (P = .02) to be the primary factors associated with peanutIgE ≥5 kUA/L. Frequency of peanut consumption during pregnancy and breast-feeding showed a dose-response association with peanutIgE ≥5 kU(A)/L, but only consumption during pregnancy was a significant predictor. Among 71 infants never breast-fed, frequent consumption of peanut during pregnancy was strongly associated with peanutIgE ≥5 kU(A)/L (odds ratio, 4.99, 95% CI, 1.69-14.74; P < .004). CONCLUSION: In this cohort of infants with likely milk or egg allergy, maternal ingestion of peanut during pregnancy was strongly associated with a high level of peanut sensitization.
Authors: T Boyano Martínez; C García-Ara; J M Díaz-Pena; F M Muñoz; G García Sánchez; M M Esteban Journal: Clin Exp Allergy Date: 2001-09 Impact factor: 5.018
Authors: David M Fleischer; Mary Kay Conover-Walker; Lynn Christie; A Wesley Burks; Robert A Wood Journal: J Allergy Clin Immunol Date: 2003-07 Impact factor: 10.793
Authors: Rhoda S Kagan; Lawrence Joseph; Claire Dufresne; Katherine Gray-Donald; Elizabeth Turnbull; Yvan St Pierre; Ann E Clarke Journal: J Allergy Clin Immunol Date: 2003-12 Impact factor: 10.793
Authors: J Tuokkola; P Luukkainen; H Tapanainen; M Kaila; O Vaarala; M G Kenward; L J Virta; R Veijola; O Simell; J Ilonen; M Knip; S M Virtanen Journal: Eur J Clin Nutr Date: 2016-01-13 Impact factor: 4.016
Authors: Scott H Sicherer; Robert A Wood; Brian P Vickery; Stacie M Jones; Andrew H Liu; David M Fleischer; Peter Dawson; Lloyd Mayer; A Wesley Burks; Alexander Grishin; Donald Stablein; Hugh A Sampson Journal: J Allergy Clin Immunol Date: 2014-02 Impact factor: 10.793
Authors: Michiko K Oyoshi; Hans C Oettgen; Talal A Chatila; Raif S Geha; Paul J Bryce Journal: J Allergy Clin Immunol Date: 2014-02 Impact factor: 10.793
Authors: David M Fleischer; Tamara T Perry; Dan Atkins; Robert A Wood; A Wesley Burks; Stacie M Jones; Alice K Henning; Donald Stablein; Hugh A Sampson; Scott H Sicherer Journal: Pediatrics Date: 2012-06-25 Impact factor: 7.124
Authors: Supinda Bunyavanich; Sheryl L Rifas-Shiman; Thomas A Platts-Mills; Lisa Workman; Joanne E Sordillo; Carlos A Camargo; Matthew W Gillman; Diane R Gold; Augusto A Litonjua Journal: J Allergy Clin Immunol Date: 2014-02-09 Impact factor: 10.793